p.101 抽出テキスト
310. Davies JE, Sen S, Dehbi HM, Al-Lamee R, Petraco R, Nijjer SS, et al. Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med 2017;376: 1824–34. https://doi.org/10.1056/NEJMoa1700445 311. Gotberg M, Christiansen EH, Gudmundsdottir IJ, Sandhall L, Danielewicz M, Jakobsen L, et al. Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. N Engl J Med 2017;376:1813–23. https://doi.org/10.1056/NEJMoa1616540 312. Faria D, Hennessey B, Shabbir A, Mejía-Rentería H, Wang L, Lee JM, et al. Functional coronary angiography for the assessment of the epicardial vessels and the microcirculation. EuroIntervention 2023;19:203–21. https://doi.org/10.4244/EIJ-D-22-00969 313. Van Belle E, Rioufol G, Pouillot C, Cuisset T, Bougrini K, Teiger E, et al. Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry. Circulation 2014;129:173–85. https://doi.org/10.1161/ CIRCULATIONAHA.113.006646 314. Lopes RD, Alexander KP, Stevens SR, Reynolds HR, Stone GW, Piña IL, et al. Initial invasive versus conservative management of stable ischemic heart disease in patients with a history of heart failure or left ventricular dysfunction. Circulation 2020;142: 1725–35. https://doi.org/10.1161/CIRCULATIONAHA.120.050304 315. Rozanski A, Miller RJH, Gransar H, Han D, Slomka P, Dey D, et al. Benefit of early revascularization based on inducible ischemia and left ventricular ejection fraction. J Am Coll Cardiol 2022;80:202–15. https://doi.org/10.1016/j.jacc.2022.04.052 316. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019;40:87–165. https://doi.org/10.1093/eurheartj/ehy394 317. Reynolds HR, Shaw LJ, Min JK, Page CB, Berman DS, Chaitman BR, et al. Outcomes in the ISCHEMIA trial based on coronary artery disease and ischemia severity. Circulation 2021;144:1024–38. https://doi.org/10.1161/CIRCULATIONAHA.120.049755 318. Johnson NP, Toth GG, Lai D, Zhu H, Açar G, Agostoni P, et al. Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. J Am Coll Cardiol 2014;64:1641–54. https://doi.org/10.1016/j.jacc.2014.07.973 319. Barbato E, Toth GG, Johnson NP, Pijls NHJ, Fearon WF, Tonino PAL, et al. A prospective natural history study of coronary atherosclerosis using fractional flow reserve. J Am Coll Cardiol 2016;68:2247–55. https://doi.org/10.1016/j.jacc.2016.08.055 320. Ciccarelli G, Barbato E, Toth GG, Gahl B, Xaplanteris P, Fournier S, et al. Angiography versus hemodynamics to predict the natural history of coronary stenoses. Circulation 2018;137:1475–85. https://doi.org/10.1161/CIRCULATIONAHA.117.028782 321. De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 2014;371: 1208–17. https://doi.org/10.1056/NEJMoa1408758 322. Van Belle E, Baptista SB, Raposo L, Henderson J, Rioufol G, Santos L, et al. Impact of routine fractional flow reserve on management decision and 1-year clinical outcome of patients with acute coronary syndromes: PRIME-FFR (Insights from the POST-IT [Portuguese Study on the Evaluation of FFR-Guided Treatment of Coronary Disease] and R3F [French FFR Registry] integrated multicenter registries—implementation of FFR [Fractional Flow Reserve] in routine practice). Circ Cardiovasc Interv 2017; 10:e004296. https://doi.org/10.1161/circinterventions.116.004296 323. Escaned J, Ryan N, Mejía-Rentería H, Cook CM, Dehbi H-M, Alegria-Barrero E, et al. Safety of the deferral of coronary revascularization on the basis of instantaneous wavefree ratio and fractional flow reserve measurements in stable coronary artery disease and acute coronary syndromes. JACC Cardiovasc Interv 2018;11:1437–49. https://doi. org/10.1016/j.jcin.2018.05.029 324. Elguindy M, Stables R, Nicholas Z, Kemp I, Curzen N. Design and rationale of the RIPCORD 2 Trial (does routine pressure wire assessment influence management strategy at coronary angiography for diagnosis of chest pain?): a randomized controlled trial to compare routine pressure wire assessment with conventional angiography in the management of patients with coronary artery disease. Circ Cardiovasc Qual Outcomes 2018;11:e004191. https://doi.org/10.1161/circoutcomes.117.004191 325. Xu B, Tu S, Song L, Jin Z, Yu B, Fu G, et al. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Lancet 2021;398:2149–59. https://doi.org/10.1016/s0140-6736(21)02248-0 326. Fearon WF, Zimmermann FM, De Bruyne B, Piroth Z, van Straten AHM, Szekely L, et al. Fractional flow reserve-guided PCI as compared with coronary bypass surgery. N Engl J Med 2022;386:128–37. https://doi.org/10.1056/NEJMoa2112299 327. Gargiulo G, Giacoppo D, Jolly SS, Cairns J, Le May M, Bernat I, et al. Effects on mortality and major bleeding of radial versus femoral artery access for coronary angiography or percutaneous coronary intervention: meta-analysis of individual patient data from 7 multicenter randomized clinical trials. Circulation 2022;146:1329–43. https://doi.org/ 10.1161/CIRCULATIONAHA.122.061527 328. Ferrante G, Rao SV, Juni P, Da Costa BR, Reimers B, Condorelli G, et al. Radial versus femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials. JACC Cardiovasc Interv 2016;9:1419–34. https://doi.org/10.1016/j.jcin.2016.04.014 329. Kolkailah AA, Alreshq RS, Muhammed AM, Zahran ME, Anas El-Wegoud M, Nabhan AF. Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in people with coronary artery disease. Cochrane Database Syst Rev 2018;4:CD012318. https://doi.org/10.1002/14651858.CD012318. pub2 330. Chiarito M, Cao D, Nicolas J, Roumeliotis A, Power D, Chandiramani R, et al. Radial versus femoral access for coronary interventions: an updated systematic review and meta-analysis of randomized trials. Catheter Cardiovasc Interv 2021;97:1387–96. https://doi.org/10.1002/ccd.29486 331. Hamilos M, Muller O, Cuisset T, Ntalianis A, Chlouverakis G, Sarno G, et al. Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation 2009;120:1505–12. https://doi.org/10.1161/CIRCULATIONAHA.109.850073 332. Zimmermann FM, Ferrara A, Johnson NP, van Nunen LX, Escaned J, Albertsson P, et al. Deferral vs. performance of percutaneous coronary intervention of functionally nonsignificant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J 2015; 36:3182–8. https://doi.org/10.1093/eurheartj/ehv452 333. Warisawa T, Cook CM, Rajkumar C, Howard JP, Seligman H, Ahmad Y, et al. Safety of revascularization deferral of left main stenosis based on instantaneous wave-free ratio evaluation. JACC Cardiovasc Interv 2020;13:1655–64. https://doi.org/10.1016/j.jcin.2020. 02.035 334. Mallidi J, Atreya AR, Cook J, Garb J, Jeremias A, Klein LW, et al. Long-term outcomes following fractional flow reserve-guided treatment of angiographically ambiguous left main coronary artery disease: a meta-analysis of prospective cohort studies. Catheter Cardiovasc Interv 2015;86:12–8. https://doi.org/10.1002/ccd.25894 335. Modi BN, van de Hoef TP, Piek JJ, Perera D. Physiological assessment of left main coronary artery disease. EuroIntervention 2017;13:820–7. https://doi.org/10.4244/eij-d-17- 00135 336. Cerrato E, Echavarria-Pinto M, D’Ascenzo F, Gonzalo N, Quadri G, Quirós A, et al. Safety of intermediate left main stenosis revascularization deferral based on fractional flow reserve and intravascular ultrasound: a systematic review and meta-regression including 908 deferred left main stenosis from 12 studies. Int J Cardiol 2018;271:42–8. https://doi.org/10.1016/j.ijcard.2018.04.032 337. Stone GW, Christiansen EH, Ali ZA, Andreasen LN, Maehara A, Ahmad Y, et al. Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis. Lancet 2024;403:824–37. https://doi.org/10.1016/S0140- 6736(23)02454-6 338. Park S-J, Kang S-J, Ahn J-M, Shim EB, Kim Y-T, Yun S-C, et al. Visual-functional mismatch between coronary angiography and fractional flow reserve. JACC Cardiovasc Interv 2012;5:1029–36. https://doi.org/10.1016/j.jcin.2012.07.007 339. Toth G, Hamilos M, Pyxaras S, Mangiacapra F, Nelis O, De Vroey F, et al. Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses. Eur Heart J 2014;35:2831–8. https://doi.org/10.1093/eurheartj/ehu094 340. Baptista SB, Raposo L, Santos L, Ramos R, Calé R, Jorge E, et al. Impact of routine fractional flow reserve evaluation during coronary angiography on management strategy and clinical outcome: one-year results of the POST-IT. Circ Cardiovasc Interv 2016;9: e003288. https://doi.org/10.1161/CIRCINTERVENTIONS.115.003288 341. Van Belle E, Gil R, Klauss V, Balghith M, Meuwissen M, Clerc J, et al. Impact of routine invasive physiology at time of angiography in patients with multivessel coronary artery disease on reclassification of revascularization strategy: results from the DEFINE REAL study. JACC Cardiovasc Interv 2018;11:354–65. https://doi.org/10.1016/j.jcin.2017.11. 030 342. Van Belle E, Dupouy P, Rioufol G. Routine fractional flow reserve combined to diagnostic coronary angiography as a one-stop procedure: episode 3. Circ Cardiovasc Interv 2016;9:e004137. https://doi.org/10.1161/CIRCINTERVENTIONS.116.004137 343. Eftekhari A, Holck EN, Westra J, Olsen NT, Bruun NH, Jensen LO, et al. Instantaneous wave free ratio vs. fractional flow reserve and 5-year mortality: iFR SWEDEHEART and DEFINE FLAIR. Eur Heart J 2023;44:4376–84. https://doi.org/10.1093/eurheartj/ ehad582 344. Berry C, McClure JD, Oldroyd KG. Coronary revascularization guided by instantaneous wave-free ratio compared to fractional flow reserve: pooled 5-year mortality in the DEFINE-FLAIR and iFR-SWEDEHEART trials. Eur Heart J 2023;44:4388–90. https://doi.org/10.1093/eurheartj/ehad552 345. Berntorp K, Rylance R, Yndigegn T, Koul S, Fröbert O, Christiansen EH, et al. Clinical outcome of revascularization deferral with instantaneous wave-free ratio and fractional flow reserve: a 5-year follow-up substudy from the iFR-SWEDEHEART Trial. J Am Heart Assoc 2023;12:e028423. https://doi.org/10.1161/jaha.122.028423 346. Rioufol G, Derimay F, Roubille F, Perret T, Motreff P, Angoulvant D, et al. Fractional flow reserve to guide treatment of patients with multivessel coronary artery disease. J Am Coll Cardiol 2021;78:1875–85. https://doi.org/10.1016/j.jacc.2021.08.061 347. Stables RH, Mullen LJ, Elguindy M, Nicholas Z, Aboul-Enien YH, Kemp I, et al. Routine pressure wire assessment versus conventional angiography in the management of patients with coronary artery disease: the RIPCORD 2 trial. Circulation 2022;146: 687–98. https://doi.org/10.1161/circulationaha.121.057793 348. Nijjer SS, Sen S, Petraco R, Escaned J, Echavarria-Pinto M, Broyd C, et al. Pre-angioplasty instantaneous wave-free ratio pullback provides virtual intervention and predicts hemodynamic outcome for serial lesions and diffuse coronary artery disease. JACC Cardiovasc Interv 2014;7:1386–96. https://doi.org/10.1016/j.jcin.2014.06.015 ESC Guidelines 3515 Downloaded from academic.oup.com/eurheartj/article/45/36/3415/7743115 by guest on 07 October 2026